FIELD: medicine. SUBSTANCE: method involves administering Wobenzym preparation to a patient at a dose of 20-30 dragee per day during 6 months and succinic elixir at a dose of 2 capsules per day during 40 days. EFFECT: enhanced effectiveness of treatment; accelerated treatment course; prolonged remission period; excluded adverse side effects.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING FOR IDIOPATHIC AND INFLAMMATORY DISEASES | 2004 |
|
RU2277938C2 |
| METHOD OF TREATMENT OF PATIENTS WITH DUCHENNE'S-BECKER'S MYODYSTROPHY DISEASE | 1998 |
|
RU2173144C2 |
| METHOD OF TREATING PROGRESSIVE MUSCULAR DYSTROPHY | 0 |
|
SU1621952A1 |
| METHOD FOR TREATMENT OF PATIENTS HAVING VERNAL ENCEPHALITIS | 0 |
|
SU1837230A1 |
| METHOD FOR TREATING DISSEMINATED SCLEROSIS | 1991 |
|
RU2016568C1 |
| METHOD OF DIFFERENTIAL MYOPATHY DIAGNOSIS | 0 |
|
SU1746309A1 |
| METHOD FOR PREDICTION OF CRISIS IN PATIENTS WITH MYASTHENIA | 2013 |
|
RU2511080C1 |
| METHOD OF PREPARATION FOR CHILDBIRTH AND POSTNATAL PERIOD IN PREGNANT WOMEN OF RISK GROUPS AT SANATORIUM STAGE | 2008 |
|
RU2389464C2 |
| MYOTONIC DYSTROPHY TREATMENT METHOD | 0 |
|
SU1635998A1 |
| METHOD OF CEREBROSPINAL SCLEROSIS TREATMENT | 0 |
|
SU1827260A1 |
